Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis
复制标题
DOI：
10.2807/1560-7917.es2014.19.6.20700
复制
发表时间：
2014-02-13
期刊：
影响因子：
19
通讯作者：
Ezpeleta, C.
中科院分区：
文献类型：
--
作者：
Castilla, J.;Martinez-Baz, I.;Ezpeleta, C.
我们估计了2013/14赛季中期西班牙纳瓦拉流感三价疫苗的疫苗效力(VE)。包括在医院(n=431)和初级保健(n=344)就诊的流感样疾病病例。在预防实验室确认的流感方面，总体调整后的VE为24%(95%CI：-14至50)。对甲型H1pdm09流感的VE为40%(95%可信区间：-12至68)，对甲型H3流感的VE为13%(95%可信区间：-36至45)。这些结果表明，对甲型流感(H1)pdm09的预防效果中等，对甲型流感(H3)的保护作用较低。
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).